Premium Nahrungsergänzungsmittel | artgerecht

Methylmalonic Acid: Meaning, Diagnosis & Treatment

Methylmalonic acid (MMA) is a metabolic byproduct formed during the breakdown of certain amino acids. Elevated levels can indicate a vitamin B12 deficiency or rare inherited metabolic disorders.

Regular tips about health Regular tips about health

Things worth knowing about "Methylmalonic acid"

Methylmalonic acid (MMA) is a metabolic byproduct formed during the breakdown of certain amino acids. Elevated levels can indicate a vitamin B12 deficiency or rare inherited metabolic disorders.

What is Methylmalonic Acid?

Methylmalonic acid (MMA) is an organic acid produced as an intermediate in the body's metabolic processes. It is generated during the breakdown of the amino acids valine, isoleucine, threonine, and methionine, as well as odd-chain fatty acids. Under normal conditions, MMA is converted to succinyl-CoA by the enzyme methylmalonyl-CoA mutase – a reaction that requires vitamin B12 (specifically adenosylcobalamin) as a cofactor. When vitamin B12 is deficient, MMA accumulates and can be detected at elevated levels in the blood and urine.

Clinical Significance

Measuring MMA levels is a valuable diagnostic tool, particularly for the following conditions:

Vitamin B12 deficiency: MMA is a sensitive and early functional marker of vitamin B12 deficiency, often rising before serum B12 levels fall or blood count abnormalities appear.
Methylmalonic acidemia: A rare inherited metabolic disorder in which the enzyme methylmalonyl-CoA mutase is defective or absent, leading to a dangerous accumulation of MMA.
Kidney insufficiency: Reduced renal excretion can cause MMA levels to rise independently of vitamin B12 status.

Causes of Elevated Methylmalonic Acid Levels

Elevated MMA concentrations may result from:

Vitamin B12 deficiency (most common cause)
Inherited defects of the methylmalonyl-CoA mutase enzyme
Defects in cobalamin metabolism (e.g., CblA or CblB defects)
Chronic kidney disease with impaired excretion
Severe dietary deficiencies (e.g., vegan diet without B12 supplementation)

Symptoms Associated with Elevated MMA Levels

Symptoms depend on the underlying cause and the severity of the elevation. In the context of vitamin B12 deficiency, patients may experience:

Fatigue and general weakness
Neurological symptoms such as tingling or numbness in the hands and feet
Difficulties with concentration and memory
Pallor and shortness of breath due to anemia

In newborns with the inherited condition methylmalonic acidemia, severe symptoms can appear shortly after birth, including feeding difficulties, vomiting, muscle weakness (hypotonia), reduced consciousness, and potentially life-threatening metabolic crises.

Diagnosis

MMA is measured from a blood or urine sample using gas chromatography-mass spectrometry (GC-MS) or high-performance liquid chromatography (HPLC). Testing is indicated in the following situations:

Suspected vitamin B12 deficiency, especially when serum B12 levels are borderline
Investigation of unexplained neurological symptoms
Newborn screening for inherited metabolic disorders
Monitoring of patients with known methylmalonic acidemia

Reference values vary by laboratory, but serum MMA is typically below 0.4 µmol/l and urinary MMA below 3.6 mmol/mol creatinine.

Treatment

Vitamin B12 Deficiency

If vitamin B12 deficiency is the underlying cause, treatment involves vitamin B12 supplementation via intramuscular injections (hydroxocobalamin or cyanocobalamin) or high-dose oral preparations. With successful treatment, MMA levels typically normalize within a few weeks.

Inherited Methylmalonic Acidemia

Management of the inherited form requires a specialized diet with restricted intake of the relevant amino acids, and in some cases high-dose vitamin B12 therapy (for cobalamin-responsive forms). Severe cases may require liver or kidney transplantation. Treatment is carried out at specialized metabolic centers.

References

Stabler, S.P. - Vitamin B12 Deficiency. New England Journal of Medicine, 2013; 368:149-160.
Manoli, I. & Venditti, C.P. - Methylmalonic Acidemia. In: Adam MP et al. (eds.), GeneReviews. University of Washington, Seattle, 1993-2024. Available via NCBI Bookshelf.
World Health Organization (WHO) - Serum and red blood cell folate concentrations for assessing folate status in populations. WHO, Geneva, 2015.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.